Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021

SELL
$221.91 - $258.6 $1.23 Million - $1.44 Million
-5,554 Closed
0 $0
Q4 2020

Feb 19, 2021

BUY
$216.38 - $257.67 $1.2 Million - $1.43 Million
5,554 New
5,554 $1.26 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track 3 D/L Capital Management, LLC Portfolio

Follow 3 D/L Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 3 D/L Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 3 D/L Capital Management, LLC with notifications on news.